Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3355
Peer-review started: April 5, 2020
First decision: April 24, 2020
Revised: May 5, 2020
Accepted: July 15, 2020
Article in press: July 15, 2020
Published online: August 6, 2020
Coronavirus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19.
We report a patient with confirmed COVID-19 combined with asthma. It took 41 d from disease onset to discharge to obtain two negative tests for this coronavirus.
This case indicates the dynamic clinical characteristics, laboratory and computed tomography findings and adjustment of treatment, and the possible relationship between glucocorticoid therapy and coronavirus clearance.
Core tip: This is a case of confirmed coronavirus disease 2019 with asthma. We reported the whole course. It took 41 d from disease onset to discharge. This case indicated dynamic clinical characteristics, laboratory findings, computed tomography images and adjustment of treatment and discussed the possible relation between glucocorticoids therapy and virus clearance.